Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia

Journal of Medical Genetics

Volumn 44, Issue 3, 2007, Pages 219-224

  Di Leo, Enza ^a   Magnolo, Lucia ^a   Lancellotti, Sandra ^a   Crocè, Lory ^b   Visintin, Luca ^b   Tiribelli, Claudio ^b   Bertolini, Stefano ^c   Calandra, Sebastiano ^a   Tarugi, Patrizia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; MESSENGER RNA; LIPID; LIPOPROTEIN; RNA PRECURSOR; SYNTHETIC DNA;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; HYPOBETALIPOPROTEINEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SPLICING; SCHOOL CHILD; ANIMAL; BLOOD; CERCOPITHECUS; CHEMISTRY; CHILD; FATTY LIVER; GENETICS; INTRON; LETTER; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADULT; ANIMALS; APOLIPOPROTEINS B; CERCOPITHECUS AETHIOPS; CHILD; COS CELLS; DNA MUTATIONAL ANALYSIS; FATTY LIVER; FEMALE; GENES, SYNTHETIC; GENOTYPE; HUMANS; HYPOBETALIPOPROTEINEMIA, FAMILIAL, APOLIPOPROTEIN B; INTRONS; LIPIDS; LIPOPROTEINS; LIVER; MALE; RNA PRECURSORS; RNA SPLICE SITES; RNA SPLICING; TRANSFECTION;

EID: 34147160262     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.046359     Document Type: Article

References (25)

1. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. Vol II. 8th edn. New York: McGraw-Hill, 2001:2717-52.
2. Schonfeld G, Lin X, Yue P. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol Life Sci 2005;62:1372-8.
3. Linton MF, Farese RV, Young SG. Familial hypobetalipoproteinemia. J Lipid Res 1993;34:521-41.
4. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PW, Shaefer EJ. Frequency of apo B and apo E gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population. Arterioscler Thromb Vasc Biol 1998;18:1745-51.
5. Tarugi P, Lonardo A, Ballarini G, Grisendi A, Pulvirenti M, Bagni A, Calandra S. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology 1996;111:1125-33.
6. Whitfield AJ, Barrett PH, Robertson K, Havlat MF, van Bockxmeer FM, Burnett JR. Liver dysfunction and steatosis in familial hypobetalipoproteinemia. Clin Chem 2005;51:266-9.
7. Tarugi P, Lonardo A, Gabelli C, Sala F, Ballarini G, Cortella I, Previato L, Bertolini S, Cordera R, Calandra S. Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene. J Lipid Res 2001;42:1552-61.
8. Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci 2005;42:515-45.
9. Burnett JR, Shan J, Miskie BA, Whitfield AJ, Yuan J, Tran K, McKnight CJ, Hegele RA, Yao Z. A novel nontruncating apoB gene mutation, R463W, causes familial hypobetalipoproteinemia. J Biol Chem 2003;278: 13442-52.
10. Huang L-S, Kayden H, Sokol RJ, Breslow JL. ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia. J Lipid Res 1991;32:1341-8.
11. Talmud PJ, Krul ES, Pessah M, Gay G, Schonfeld G, Humphries SE, Infante R. Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia. J Lipid Res 1994;35:468-77.
12. Welty FK, Guida KA, Andersen JJ. Donor splice site mutation (210+1 G_C) in the apo B gene causes a very low level of apo B-100 and LDL cholesterol. Arterioscler Thromb Vasc Biol 2001;21:1864-5.
13. Hegele RA, Miskie BA. Acanthocytosis in a patient with homozygous familial hypobetalipoproteinemia due to a novel APOB splice site mutation. Clin Genet 2002;61:101-3.
14. Yue P, Yuan B, Gerhard DS, Neuman RG, Isley WL, Harris WS, Schonfeld G. Novel mutations of apo B cause apo B truncations undetectable in plasma and familial hypobetalipoproteinemia. Hum Mutat 2002;20:110-16.
15. Whitfield AJ, Marais AD, Robertson K, Barrett PHR, van Bockxmeer FM, Burnett JR. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia. Hum Mutat 2003;22:178.
16. Pulai J, Zakeri H, Kwok P-Y, Kim JH, Wu J, Schonfeld G. Donor splice mutation (665+1GT) in familial hypobetalipoproteinemia with no detectable apo B truncation. Am J Med Genet 1998;80:218-20.
17. Nemeth-Slany A, Talmud P, Grundy SM, Patel SB. Activation of a cryptic splice-site in intron 24 leads to the formation of apolipoprotein B-27.6. Atherosclerosis 1997;133:163-70.
18. Tarugi P, Lonardo A, Ballarini G, Erspamer L, Tondelli E, Bertolini S, Calandra S. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apoB-54.5). J Hepatol 2000;33:361-70.
19. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12.
20. den Dunnen JT, Paalman MH. Standardizing mutation nomenclature: why bother? Hum Mutat 2003;22:181-2.
21. Nalla VK, Rogan PK. Automated splicing mutation analysis by information theory. Hum Mutat 2005;25:334-42.
22. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Ann Rev Biochem 2003;72:291-336.
23. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002;3:285-98.
24. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet 2004;36:801-8.
25. Bjorkegren J, Beigneux A, Bergo MO, Maher JJ, Young SG. Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induce injury. J Biol Chem 2002;277:5476-83.